JSJ. Philip Saul

J. Philip Saul

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


J. Philip Saul has a total of 87 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Toddler cavotricuspid valve isthmus ablation for typical atrial flutter with cryoablation

    by Mohammad Ebrahim A, Mohamed Abdelnaby A, Phil Saul

    Case presentation: We describe the youngest successful cavotricupsid isthmus cryoablation in a toddler with small atrial septal defect whose medical management was complicated with intrinsic conduction disease and recurrent atrial flutter. Methods: Zero fluoroscopy electrophysiology study performed. Cavotricuspid isthmus proved to be “in” circuit with entrainment. Line of block was achieved with termination of atrial flutter using 2 minutes cryo-lesions. Results: The patient underwent successful cryoablation at 9 kg, without recurrence. Conclusion: Cavotricuspid isthmus ablation using cryoablation resulted in no recurrence of atrial flutter for at least 1 year of follow up. Ablation offers a less invasive approach (versus pacemaker implantation) for toddlers with coexisting conduction disease, limiting medical management option.

  • Open Access

    Factors Associated With Sinoatrial Reinnervation After Heart Transplantation

    by Anders H. Christensen, Vegard B.B. Wyller, Sissel Nygaard, Katrine Rolid, Kari Nytrøen, Lars Gullestad, Arnt Fiane, Erik Thaulow, J. Philip Saul, Gaute Døhlen

    Background. Factors associated with sympathetic and parasympathetic sinoatrial reinnervation after heart transplantation (HTx) are inadequately studied. Methods. Fifty transplant recipients were examined at 7 to 12 wk (index visit), 6, 12, 24, and 36 mo after HTx. Supine rest heart rate variability in the low-frequency (LF) domain (sympathetic and parasympathetic sinoatrial reinnervation) and the high-frequency (HF) domain (parasympathetic sinoatrial reinnervation) were measured repeatedly and related to selected recipient, donor, and perisurgical characteristics. We primarily aimed to identify index visit factors that affect the sinoatrial reinnervation process. Secondarily, we examined overall associations between indices of reinnervation and repeatedly measured recipient characteristics to generate new hypotheses regarding the consequences of reinnervation. Results. LF and HF variability increased time dependently. In multivariate modeling, a pretransplant diagnosis of nonischemic cardiomyopathy (P = 0.038) and higher index visit handgrip strength (P = 0.028) predicted improved LF variability. Recipient age, early episodes of rejection, and duration of extracorporeal circulation were not associated with indices of reinnervation. Study average handgrip strength was positively associated with LF and HF variability (respectively, P = 0.005 and P = 0.029), whereas study average C-reactive protein was negatively associated (respectively, P = 0.015 and P = 0.008). Conclusions. Indices of both sympathetic and parasympathetic sinoatrial reinnervation increased with time after HTx. A pretransplant diagnosis of nonischemic cardiomyopathy and higher index visit handgrip strength predicted higher indices of mainly sympathetic reinnervation, whereas age, rejection episodes, and duration of extracorporeal circulation had no association. HTx recipients with higher indices of reinnervation had higher average handgrip strength, suggesting a link between reinnervation and improved frailty. The more reinnervated participants had lower average C-reactive protein, suggesting an inhibitory effect of reinnervation on inflammation, possibly through enhanced function of the inflammatory reflex. These potential effects of reinnervation may affect long-term morbidity in HTx patients and should be scrutinized in future research. Export


  • Open Access

    IV Sotalol Use in Pediatric and Congenital Heart Patients: A Multicenter Registry Study

    by Lindsey E. Malloy‐Walton, Nicholas H. Von Bergen, Seshadri Balaji, Peter S. Fischbach, Jason M. Garnreiter, S. Yukiko Asaki, Jeffrey P. Moak, Luis A. Ochoa, Philip M. Chang, Hoang H. Nguyen, et al.

    Background: There is limited information regarding the clinical use and effectiveness of IV sotalol in pediatric patients and patients with congenital heart disease, including those with severe myocardial dysfunction. A multicenter registry study was designed to evaluate the safety, efficacy, and dosing of IV sotalol. Methods and Results: A total of 85 patients (age 1 day–36 years) received IV sotalol, of whom 45 (53%) had additional congenital cardiac diagnoses and 4 (5%) were greater than 18 years of age. In 79 patients (93%), IV sotalol was used to treat supraventricular tachycardia and 4 (5%) received it to treat ventricular arrhythmias. Severely decreased cardiac function by echocardiography was seen before IV sotalol in 7 (9%). The average dose was 1 mg/kg (range 0.5–1.8 mg/kg/dose) over a median of 60 minutes (range 30–300 minutes). Successful arrhythmia termination occurred in 31 patients (49%, 95% CI [37%–62%]) with improvement in rhythm control defined as rate reduction permitting overdrive pacing in an additional 18 patients (30%, 95% CI [19%–41%]). Eleven patients (16%) had significant QTc prolongation to >465 milliseconds after the infusion, with 3 (4%) to >500 milliseconds. There were 2 patients (2%) for whom the infusion was terminated early. Conclusions: IV sotalol was safe and effective for termination or improvement of tachyarrhythmias in 79% of pediatric patients and patients with congenital heart disease, including those with severely depressed cardiac function. The most common dose, for both acute and maintenance dosing, was 1 mg/kg over ~60 minutes with rare serious complications.


  • Relation of Norwood Shunt Type and Frequency of Arrhythmias at 6 Years (from the Single Ventricle Reconstruction Trial)

    by Nicole Cain, J. Philip Saul, Russell Gongwer, Felicia Trachtenberg, Richard J. Czosek, Jeffrey J. Kim, Jonathon R. Kaltman, Martin J. LaPage, Christopher M. Janson, Anoop K. Singh, et al.


  • Open Access

    Heart rate variability and the dawn of complex physiological signal analysis: methodological and clinical perspectives

    by J. Philip Saul, Gaetano Valenza

    Spontaneous beat-to-beat variations of heart rate (HR) have intrigued scientists and casual observers for centuries; however, it was not until the 1970s that investigators began to apply engineering tools to the analysis of these variations, fostering the field we now know as heart rate variability or HRV . Since then, the field has exploded to not only include a wide variety of traditional linear time and frequency domain applications for the HR signal, but also more complex linear models that include additional physiological parameters such as respiration, arterial blood pressure, central venous pressure and autonomic nerve signals. Most recently, the field has branched out to address the nonlinear components of many physiological processes, the complexity of the systems being studied and the important issue of specificity for when these tools are applied to individuals. When the impact of all these developments are combined, it seems likely that the field of HRV will soon begin to realize its potential as an important component of the toolbox used for diagnosis and therapy of patients in the clinic. This article is part of the theme issue 'Advanced computation in cardiovascular physiology: new challenges and opportunities'.


  • “A Song of Ice and Fire”—another verse from the world of ablation

    by J. Philip Saul, Martin J. LaPage

    The debate between the use of radiofrequency (RF) or cryoenergy for ablation near the atrioventricular (AV) conducting system or small coronaries has been fueled by the relative efficacies and risks of the two technologies, particularly in smaller hearts. The manuscript by Schneider et al adds another chapter to that ongoing debate.

  • Top Cited Papers

    PACES/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease

    by J. Philip Saul, Ronald J. Kanter, Dominic Abrams, Sam Asirvatham, Yaniv Bar-Cohen, Andrew D. Blaufox, Bryan Cannon, John Clark, Macdonald Dick, Anne Freter, et al.


  • Task Force 4: Pediatric Cardiology Fellowship Training in Electrophysiology

    by Anne M. Dubin, Edward P. Walsh, Wayne Franklin, Ronald J. Kanter, J. Philip Saul, Maully J. Shah, George F. Van Hare, Julie A. Vincent


  • Acute Cardiac Resynchronization Therapy for the Failing Left, Right, or Single Ventricle After Repaired Congenital Heart Disease

    by Mitchell Cohen, J. Philip Saul, Anjan S. Batra, Richard Friedman, Jan Janoušek

    Use of cardiac resynchronization in children and young adults with congenital heart disease has been described in a variety of anecdotal cases and pooled institutional summaries which report mid-term results. This manuscript addresses use of cardiac resynchronization and/or multisite pacing in children in the acute postoperative period with a failing right, left, or single ventricle.


  • Convective Cooling Effect on Cooled‐Tip Catheter Compared to Large‐Tip Catheter Radiofrequency Ablation

    by Thomas A. Pilcher, Anna L. Sanford, J. Philip Saul, Dieter Haemmerich

    Background. Both actively cooled‐tip and large‐tip catheters are currently available clinically to create large endomyocardial lesions during application of radiofrequency (RF) energy. The purpose of this study was to compare the effect of convective cooling at physiologic flow rates on RF lesion size using both actively cooled and large‐tip catheters. Methods. Porcine hearts were sectioned into 72 pieces and placed in a temperature‐controlled saline bath (37°C) with varying directed flow rates (0, 1, 2, and 3 L/min). Cooled‐tip RF ablation (4 mm tip) was performed for 1 minute on 36 tissue sections with power manually titrated to keep tip temperature below 40°C. Large‐tip catheter ablation (10 mm tip) was performed at 65°C target temperature for 1 minute on 36 tissue sections. For each catheter, flow rates were randomized between applications. The tissue pieces were sectioned and measured to determine lesion depth, width, and volume. Results. Lesion dimensions were independent of the flow rate for the cooled‐tip catheter (mean volumes: 382.0 ± 121.6, 419.9 ± 133.4, 375.9 ± 169.1, and 346.7 ± 173.4 mm3 for 0, 1, 2, and 3 L/min flow rate, respectively, P = 0.78). For the large‐tip catheter, lesion size varied significantly with flow, such that higher flow rates produced larger lesions (mean volumes: 120.7 ± 50.7, 256.5 ± 97.9, 393.4 ± 149.9, and 548.9 ± 157.0 mm3 for 0, 1, 2, and 3 L/min flow rate respectively, P < 0.001) Conclusion. During RF ablation, blood flow rate significantly affects lesion size for large‐tip but not cooled‐tip catheters. At low flow rates (0–1 L/min) cooled‐tip catheters create larger lesions, while at high flow rates (3 L/min) large‐tip catheters create larger lesions.